1
|
Zhang H, Wang Y, Wang Y, Li X, Wang S, Wang Z. Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease. Eur J Med Chem 2022; 240:114606. [PMID: 35858523 DOI: 10.1016/j.ejmech.2022.114606] [Citation(s) in RCA: 25] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Revised: 07/08/2022] [Accepted: 07/09/2022] [Indexed: 12/17/2022]
Abstract
Alzheimer's disease (AD), as the fourth leading cause of death among the elderly worldwide, has brought enormous challenge to the society. Due to its extremely complex pathogeneses, the development of multi-target directed ligands (MTDLs) becomes the major strategy for combating AD. Carbamate moiety, as an essential building block in the development of MTDLs, exhibits structural similarity to neurotransmitter acetylcholine (ACh) and has piqued extensive attention in discovering multifunctional cholinesterase inhibitors. To date, numerous preclinical studies demonstrate that carbamate-based cholinesterase inhibitors can prominently increase the level of ACh and improve cognition impairments and behavioral deficits, providing a privileged strategy for the treatment of AD. Based on the recent research focus on the novel cholinesterase inhibitors with multiple biofunctions, this review aims at summarizing and discussing the most recent studies excavating the potential carbamate-based MTDLs with cholinesterase inhibition efficacy, to accelerate the pace of pleiotropic cholinesterase inhibitors for coping AD.
Collapse
Affiliation(s)
- Honghua Zhang
- School of Pharmacy, Lanzhou University, Lanzhou, 730000, China
| | - Yuying Wang
- State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou, 730000, China
| | - Yuqing Wang
- School of Pharmacy, Lanzhou University, Lanzhou, 730000, China
| | - Xuelin Li
- School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
| | - Shuzhi Wang
- School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
| | - Zhen Wang
- The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China; School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
| |
Collapse
|
2
|
Elrayess R, Darwish KM, Nafie MS, El-Sayyed GS, Said MM, Yassen ASA. Quinoline–hydrazone hybrids as dual mutant EGFR inhibitors with promising metallic nanoparticle loading: rationalized design, synthesis, biological investigation and computational studies. NEW J CHEM 2022. [DOI: 10.1039/d2nj02962f] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A novel quinoline–hydrazone hybrid induced apoptosis in MCF-7 cells through dual mutant EGFR inhibition with promising metallic nanoparticle loading.
Collapse
Affiliation(s)
- Ranza Elrayess
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt
| | - Khaled M. Darwish
- Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt
| | - Mohamed S. Nafie
- Chemistry Department, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt
| | - Gharieb S. El-Sayyed
- Microbiology and Immunology Department, Faculty of Pharmacy, Galala University, New Galala City, Suez, Egypt
- Drug Radiation Research Department, National Centre for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt
| | - Mohamed M. Said
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt
| | - Asmaa S. A. Yassen
- Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt
| |
Collapse
|
3
|
Zhao Y, Dong Y, Ge Q, Cui P, Sun N, Lin S. Neuroprotective effects of NDEELNK from sea cucumber ovum against scopolamine-induced PC12 cell damage through enhancing energy metabolism and upregulation of the PKA/BDNF/NGF signaling pathway. Food Funct 2021; 12:7676-7687. [PMID: 34259275 DOI: 10.1039/d1fo00631b] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
The aim of the study was to evaluate the neuroprotective function of sea cucumber ovum peptide-derived NDEELNK and explore the underlying molecular mechanisms. NDEELNK exerted the neuroprotective effect by improving the acetylcholine (ACh) level and reducing the acetylcholinesterase (AChE) activity in PC12 cells. By molecular docking, we confirmed that the NDEELNK backbone and AChE interacted through hydrophobic and hydrogen bonds in contact with the amino acid residues of the cavity wall. NDEELNK increased superoxide dismutase (SOD) activity and decreased reactive oxygen species (ROS) production, thereby reducing mitochondrial dysfunction and enhancing energy metabolism. Our results demonstrated that NDEELNK supplementation alleviated scopolamine-induced PC12 cell damage by improving the cholinergic system, increasing energy metabolism and upregulating the expression of phosphorylated protein kinase A (p-PKA), brain-derived neurotrophic factor (BNDF) and nerve growth factor (NGF) signaling proteins in in vitro experiments. These results demonstrated that the sea cucumber ovum peptide-derived NDEELNK might play a protective role in PC12 cells.
Collapse
Affiliation(s)
- Yue Zhao
- National Engineering Research Center of Seafood, School of Food Science and Technology, Dalian Polytechnic University, Dalian 116034, P. R. China.
| | | | | | | | | | | |
Collapse
|
4
|
Yamazaki DAS, Rozada AMF, Baréa P, Reis EC, Basso EA, Sarragiotto MH, Seixas FAV, Gauze GF. Novel arylcarbamate-N-acylhydrazones derivatives as promising BuChE inhibitors: Design, synthesis, molecular modeling and biological evaluation. Bioorg Med Chem 2021; 32:115991. [PMID: 33440318 DOI: 10.1016/j.bmc.2020.115991] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2020] [Revised: 12/14/2020] [Accepted: 12/28/2020] [Indexed: 12/31/2022]
Abstract
A novel series of arylcarbamate-N-acylhydrazones derivatives have been designed and synthesized as potential anti-cholinesterase agents. In vitro studies revealed that these compounds demonstrated selective for butyrylcholinesterase (BuChE) with potent inhibitory activity. The compounds 10a-d, 12b and 12d were the most potent BuChE inhibitors with IC50 values of 0.07-2.07 µM, highlighting the compound 10c (IC50 = 0.07 µM) which showed inhibitory activity 50 times greater than the reference drug donepezil (IC50 = 3.54 µM). The activity data indicates that the position of the carbamate group in the aromatic ring has a greater influence on the inhibitory activity of the derivatives. The enzyme kinetics studies indicate that the compound 10c has a non-competitive inhibition against BuChE with Ki value of 0.097 mM. Molecular modeling studies corroborated the in vitro inhibitory mode of interaction and show that compound 10c is stabilized into hBuChE by strong hydrogen bond interaction with Tyr128, π-π stacking interaction with Trp82 and CH⋯O interactions with His438, Gly121 and Glu197. Based on these data, compound10cwas identified as low-cost promising candidate for a drug prototype for AD treatment.
Collapse
Affiliation(s)
- Diego A S Yamazaki
- Department of Chemistry, State University of Maringá, Maringá, PR, Brazil
| | - Andrew M F Rozada
- Department of Chemistry, State University of Maringá, Maringá, PR, Brazil
| | - Paula Baréa
- Department of Chemistry, State University of Maringá, Maringá, PR, Brazil
| | - Elaine C Reis
- Department of Chemistry, State University of Maringá, Maringá, PR, Brazil
| | - Ernani A Basso
- Department of Chemistry, State University of Maringá, Maringá, PR, Brazil
| | | | - Flávio A V Seixas
- Department of Technology, State University of Maringá, Umuarama, PR, Brazil
| | - Gisele F Gauze
- Department of Chemistry, State University of Maringá, Maringá, PR, Brazil.
| |
Collapse
|
5
|
Yu Z, Ji H, Shen J, Kan R, Zhao W, Li J, Ding L, Liu J. Identification and molecular docking study of fish roe-derived peptides as potent BACE 1, AChE, and BChE inhibitors. Food Funct 2020; 11:6643-6651. [DOI: 10.1039/d0fo00971g] [Citation(s) in RCA: 27] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and beta-secretase 1 (BACE 1) play vital roles in the development and progression of Alzheimer's disease (AD).
Collapse
Affiliation(s)
- Zhipeng Yu
- College of Food Science and Engineering
- Bohai University
- Jinzhou 121013
- P.R. China
| | - Huizhuo Ji
- College of Food Science and Engineering
- Bohai University
- Jinzhou 121013
- P.R. China
| | - Juntong Shen
- College of Food Science and Engineering
- Bohai University
- Jinzhou 121013
- P.R. China
| | - Ruotong Kan
- College of Food Science and Engineering
- Bohai University
- Jinzhou 121013
- P.R. China
| | - Wenzhu Zhao
- College of Food Science and Engineering
- Bohai University
- Jinzhou 121013
- P.R. China
| | - Jianrong Li
- College of Food Science and Engineering
- Bohai University
- Jinzhou 121013
- P.R. China
| | - Long Ding
- College of Food Science and Engineering
- Northwest A&F University
- Yangling 712100
- P.R. China
| | - Jingbo Liu
- Lab of Nutrition and Functional Food
- Jilin University
- Changchun 130062
- P.R. China
| |
Collapse
|
6
|
Marra RKF, Kümmerle AE, Guedes GP, Barros CDS, Gomes RSP, Cirne-Santos CC, Paixão ICNP, Neves AP. Quinolone-N-acylhydrazone hybrids as potent Zika and Chikungunya virus inhibitors. Bioorg Med Chem Lett 2019; 30:126881. [PMID: 31843348 DOI: 10.1016/j.bmcl.2019.126881] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2019] [Revised: 11/04/2019] [Accepted: 11/30/2019] [Indexed: 12/20/2022]
Abstract
This work reports the synthesis of quinolone-N-acylhydrazone hybrids, namely 6-R-N'-(2-hydxoxybenzylidene)-4-oxo-1,4-dihydroquinoline-3-carbohydrazide (R = H: 5a, F: 5b, Cl: 5c and Br: 5d), which exhibited excellent activity against arbovirus Zika (ZIKV) and Chikungunya (CHIKV). In vitro screening towards ZIKV and CHIKV inhibition revealed that all substances have significant antiviral activity, most of them being more potent than standard Ribavirin (5a-d: EC50 = 0.75-0.81 μM, Ribavirin: EC50 = 3.95 μM for ZIKV and 5a-d: 1.16-2.85 μM, Ribavirin: EC50 = 2.42 μM for CHIKV). The quinolone-N-acylhydrazone hybrids were non-toxic against Vero cells, in which compounds 5c and 5d showed the best selectivities (SI = 1410 and 630 against ZIKV and CHIKV, respectively). Antiviral activity was identified by inhibition of viral RNA production in a dose-dependent manner. In the evaluation of the time of addition of the compounds, we observed that 5b and 5c remain with strong effect even in the addition for 12 h after infection. The above results indicate that quinolone-N-acylhydrazones represent a new and promising class to be further investigated as anti-ZIKV and anti-CHIKV agents.
Collapse
Affiliation(s)
- Roberta K F Marra
- Instituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ 23897-000, Brazil
| | - Arthur E Kümmerle
- Instituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ 23897-000, Brazil
| | - Guilherme P Guedes
- Instituto de Química, Universidade Federal Fluminense, Niterói, RJ 24020-141, Brazil
| | - Caroline de S Barros
- Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ 24020-141, Brazil
| | - Rafaela S P Gomes
- Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ 24020-141, Brazil
| | | | | | - Amanda P Neves
- Instituto de Química, Universidade Federal Rural do Rio de Janeiro, Seropédica, RJ 23897-000, Brazil.
| |
Collapse
|
7
|
Gomes RC, Sakata RP, Almeida WP, Coelho F. Spirocyclohexadienones as an Uncommon Scaffold for Acetylcholinesterase Inhibitory Activity. Med Chem 2019; 15:373-382. [PMID: 30411689 DOI: 10.2174/1573406414666181109114214] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2018] [Revised: 10/04/2018] [Accepted: 10/30/2018] [Indexed: 01/14/2023]
Abstract
BACKGROUND The most important cause of dementia affecting elderly people is the Alzheimer's disease (AD). Patients affected by this progressive and neurodegenerative disease have severe memory and cognitive function impairments. Some medicines used for treating this disease in the early stages are based on inhibition of acetylcholinesterase. Population aging should contribute to increase the cases of patients suffering from Alzheimer's disease, thus requiring the development of new therapeutic entities for the treatment of this disease. METHODS The objective of this work is to identify new substances that have spatial structural similarity with donepezil, an efficient commercial drug used for the treatment of Alzheimer's disease, and to evaluate the capacity of inhibition of these new substances against the enzyme acetylcholinesterase. RESULTS Based on a previous results of our group, we prepared a set of 11 spirocyclohexadienones with different substitutions patterns in three steps and overall yield of up to 59%. These compounds were evaluated in vitro against acetylcholinesterase. We found that eight of them are able to inhibit the acetylcholinesterase activity, with IC50 values ranging from 0.12 to 12.67 µM. Molecular docking study indicated that the spirocyclohexadienone, 9e (IC50 = 0.12 µM), a mixedtype AChE inhibitor, showed a good interaction at active site of the enzyme, including the cationic (CAS) and the peripheral site (PAS). CONCLUSION We described the first study aimed at investigating the biological properties of spirocyclohexadienones as acetylcholinesterase inhibitors. Thus, we have identified an inhibitor, which provided valuable insights for further studies aimed at the discovery of more potent acetylcholinesterase inhibitors.
Collapse
Affiliation(s)
- Ralph C Gomes
- LaboratOrio de SIntese de Produtos Naturais e Farmacos - Institute of Chemistry, University of Campinas, PO Box 6154 - 13083-970 - Campinas, SP, Brazil
| | - Renata P Sakata
- LaboratOrio de SIntese de Produtos Naturais e Farmacos - Institute of Chemistry, University of Campinas, PO Box 6154 - 13083-970 - Campinas, SP, Brazil
| | - Wanda P Almeida
- LaboratOrio de SIntese de Produtos Naturais e Farmacos - Institute of Chemistry, University of Campinas, PO Box 6154 - 13083-970 - Campinas, SP, Brazil.,Faculty of Pharmaceutical Sciences, University of Campinas, PO Box 6029 - 13083-871, Campinas, SP - Brazil
| | - Fernando Coelho
- LaboratOrio de SIntese de Produtos Naturais e Farmacos - Institute of Chemistry, University of Campinas, PO Box 6154 - 13083-970 - Campinas, SP, Brazil
| |
Collapse
|
8
|
Fernandes TB, Cunha MR, Sakata RP, Candido TM, Baby AR, Tavares MT, Barbosa EG, Almeida WP, Parise-Filho R. Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease. Arch Pharm (Weinheim) 2017; 350. [PMID: 28940630 DOI: 10.1002/ardp.201700163] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2017] [Revised: 09/01/2017] [Accepted: 09/05/2017] [Indexed: 12/19/2022]
Abstract
Alzheimer's disease (AD) is the most common type of dementia and related to the degeneration of hippocampal cholinergic neurons, which dramatically affects cognitive ability. Acetylcholinesterase (AChE) inhibitors are employed as drugs for AD therapy. Three series of sulfonylhydrazone compounds were designed, and their ability to inhibit AChE was evaluated. Fifteen compounds were synthesized and twelve of them had IC50 values of 0.64-51.09 μM. The preliminary structure-activity relationships indicated that the methylcatechol moiety and arylsulfonyl substituents generated better compounds than both the benzodioxole and alkylsulfonyl chains. Molecular dynamics studies of compound 6d showed that the interaction with the peripheral binding site of AChE was similar to donepezil, which may explain its low IC50 (0.64 μM). Furthermore, the drug-likeness of 6d suggests that the compound may have appropriate oral absorption and brain penetration. Compound 6d also presented antiradical activity and was not cytotoxic to LL24 cells, suggesting that this compound might be considered safe. Our findings indicate that arylsulfonylhydrazones may be a promising scaffold for the design of new drug candidates for the treatment of AD.
Collapse
Affiliation(s)
- Thais B Fernandes
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of São Paulo, São Paulo, Brazil
| | - Micael R Cunha
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of São Paulo, São Paulo, Brazil
| | - Renata P Sakata
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of Campinas, Campinas, Brazil
| | - Thalita M Candido
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of São Paulo, São Paulo, Brazil
| | - André R Baby
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of São Paulo, São Paulo, Brazil
| | - Maurício T Tavares
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of São Paulo, São Paulo, Brazil
| | - Euzébio G Barbosa
- Health Sciences Centre, Department of Pharmacy, Federal University of Rio Grande do Norte, Natal, Brazil
| | - Wanda P Almeida
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of Campinas, Campinas, Brazil
| | - Roberto Parise-Filho
- Faculty of Pharmaceutical Sciences, Department of Pharmacy, University of São Paulo, São Paulo, Brazil
| |
Collapse
|
9
|
Dyniewicz J, Lipiński PFJ, Kosson P, Leśniak A, Bochyńska-Czyż M, Muchowska A, Tourwé D, Ballet S, Misicka A, Lipkowski AW. Hydrazone Linker as a Useful Tool for Preparing Chimeric Peptide/Nonpeptide Bifunctional Compounds. ACS Med Chem Lett 2017; 8:73-77. [PMID: 28105278 DOI: 10.1021/acsmedchemlett.6b00381] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2016] [Accepted: 11/01/2016] [Indexed: 01/14/2023] Open
Abstract
The area of multitarget compounds, joining two pharmacophores within one molecule, is a vivid field of research in medicinal chemistry. Not only pharmacophoric elements are essential for the design and activity of such compounds, but the type and length of linkers used to connect them are also crucial. In the present contribution, we describe compound 1 in which a typical opioid peptide sequence is combined with a fragment characteristic for neurokinin-1 receptor (NK1R) antagonists through a hydrazone bridge. The compound has a high affinity for μ- and δ-opioid receptors (IC50= 12.7 and 74.0 nM, respectively) and a weak affinity for the NK1R. Molecular modeling and structural considerations explain the observed activities. In in vivo test, intrathecal and intravenous administrations of 1 exhibited a strong analgesic effect, which indicates potential BBB penetration. This letter brings an exemplary application of the hydrazone linker for fast, facile, and successful preparation of chimeric compounds.
Collapse
Affiliation(s)
- Jolanta Dyniewicz
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| | - Piotr F. J. Lipiński
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| | - Piotr Kosson
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| | - Anna Leśniak
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| | - Marta Bochyńska-Czyż
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| | - Adriana Muchowska
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| | - Dirk Tourwé
- Research
Group of Organic Chemistry, Departments of Chemistry and Bio-engineering
Sciences, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium
| | - Steven Ballet
- Research
Group of Organic Chemistry, Departments of Chemistry and Bio-engineering
Sciences, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium
| | - Aleksandra Misicka
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| | - Andrzej W. Lipkowski
- Department
of Neuropeptides, Mossakowski Medical Research Centre Polish Academy of Sciences, 5 Pawińskiego Str., 02-106 Warsaw, Poland
| |
Collapse
|